Key result
Obese hypertensive men have ~12% higher plasma angiotensinogen than normotensives, linked to 24-hour ambulatory BP.
Why the study?
The introduction of therapies inhibiting hepatic angiotensinogen synthesis renewed interest in the role of angiotensinogen in hypertension, particularly following observations of higher than expected renin-angiotensin-system activity in obese hypertensive men.
Is plasma angiotensinogen associated with higher 24-hour ambulatory blood pressure independently of plasma angiotensin II in obese men?
Cross-Sectional (n=104)
Is plasma angiotensinogen associated with higher 24-hour ambulatory blood pressure independently of plasma angiotensin II in obese men?
Plasma angiotensinogen is associated with higher 24-hour ambulatory blood pressure independently of angiotensin II in obese men, highlighting its potential role as a therapeutic target or risk marker in hypertension.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in obese hypertension; leaves open angiotensinogen's role as marker or target independent of angiotensin II.
The introduction of liver-targeted antisense oligonucleotides and small interfering ribonucleic acids that inhibit hepatic angiotensinogen synthesis has led to renewed interest in the role of angiotensinogen in hypertension. Therefore, we decided to do further angiotensinogen analyses in a hypertension research program, where we found that obese hypertensive men, given their high salt intake and high 24-hour ambulatory blood pressure (ABP), had higher than expected renin-angiotensin-system (RAS) activity. In a cross-sectional study, we examined 64 newly diagnosed treatment-naïve obese hypertension men (body mass index (BMI) ≥30 kg/m 2 , 24-hour systolic ABP ≥130 mm Hg and/or 24-hour diastolic ABP ≥80 mm Hg), and 40 obese normotensive men (BMI ≥30 mg/m 2 , 24-hour systolic ABP <130 and 24-hour diastolic ABP <80 mm Hg). Blood for biochemical evaluation of the RAS was drawn after 60 minutes rest in the supine position. We applied multiple linear regression analysis to explore independent associations. The obese hypertensive men had a higher mean fasting plasma concentration of angiotensinogen than the obese normotensive men (970.4±214.3 nmol/L versus 868.4±173.0 nmol/L, P =0.013). Adjusted for age and angiotensin II, angiotensinogen was significantly associated with 24-hour systolic ABP (regression coefficient±standard error (mm Hg/100 nmol/L angiotensinogen): 1.8±0.6, P =0.006), 24-hour diastolic ABP (0.8±0.3, P =0.021), and 24-hour pulse pressure (1.0±0.4, P =0.028). Thus, plasma angiotensinogen was associated with higher 24-hour ABPs independently of plasma angiotensin II in obese men. However, further studies are warranted to determine whether angiotensinogen is only a risk marker of high BP or has BP raising effects independent of angiotensin II. • New drugs that inhibit hepatic angiotensinogen synthesis have been developed. • This had led to new interest in the role of angiotensinogen in hypertension. • We show that angiotensinogen associates with higher blood pressure. • Surprisingly, this association is independent of angiotensin II.
No takes yet. Share an insight, caveat, or question.
Asferg et al. (2025) conducted a cross-sectional in Obesity and hypertension (n=104). Obese hypertensive status vs. Obese normotensive status was evaluated on Fasting plasma concentration of angiotensinogen (nmol/L) (p=0.013). Plasma angiotensinogen was higher in obese hypertensive men than normotensive men and independently associated with 24-hour ambulatory blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: